Forest Sees Two Potential Fibromyalgia Indications For Milnacipran
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest has two potential indications for its fibromyalgia therapy milnacipran, President & Chief Operating Officers Ken Goodman said during the firm's July 19 investor call